Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GQ7L
|
|||
| Drug Name |
PMID26161698-Compound-25
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER INTELLECTUAL PROPERTY GMBH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H21F2N5O2S
|
|||
| Canonical SMILES |
CS(=N)(=O)CC1=CC(=CC=C1)NC2=NC=NC(=N2)C3=C(C=C(C=C3)F)OCC4=CC(=CC=C4)F
|
|||
| InChI |
1S/C24H21F2N5O2S/c1-34(27,32)14-17-5-3-7-20(11-17)30-24-29-15-28-23(31-24)21-9-8-19(26)12-22(21)33-13-16-4-2-6-18(25)10-16/h2-12,15,27H,13-14H2,1H3,(H,28,29,30,31)
|
|||
| InChIKey |
YPAQXRURXUKFGB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.